Application of genomeceuticals to the molecular and immunological aspects of autism
- 31 August 2001
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 57 (2) , 186-191
- https://doi.org/10.1054/mehy.2001.1331
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Genomic multi-level nutrient-sensing pathwaysMedical Hypotheses, 2001
- Is autism a G-alpha protein defect reversible with natural vitamin A?Medical Hypotheses, 2000
- Role of Sarcolectin (SCL) and Interferons in Coordinated T Cell Clonal ExpansionJournal of Interferon & Cytokine Research, 2000
- Cloning and Expression Analysis of a Novel Gene, RP42, Mapping to an Autism Susceptibility Locus on 6q16Genomics, 2000
- Specific Inhibitors of Dipeptidyl Peptidase IV Suppress mRNA Expression of DP IV/CD26 and CytokinesPublished by Springer Nature ,2000
- Sequence, Purification, and Cloning of an Intracellular Serine Protease, Quiescent Cell Proline DipeptidaseJournal of Biological Chemistry, 1999
- Purification and Identification of Potentially Bioactive Peptides from Enzyme-Modified CheeseJournal of Dairy Science, 1999
- Protective Effect of β‐Glucan Against Mycobacterium bovis, BCG Infection in BALB/c MiceScandinavian Journal of Immunology, 1998
- On the front lines: intraepithelial lymphocytes as primary effectors of intestinal immunitySpringer Seminars in Immunopathology, 1997
- Galactose effects on enterocyte differentiation in the mouse jejunumBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991